An efficient in vivo -inducible CRISPR interference system for group A Streptococcus genetic analysis and pathogenesis studies
mBio · 14.08.2024 · 15 (8)
DOI: 10.1128/mbio.00840-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 14.08.2024. Verfasst von Elisabet Bjånes und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of California San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Streptococcus pyogenes, Streptococcal Infections, CRISPR-Cas Systems. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDCR NIH HHS, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF).
Abstract (Originalsprache)
While genome-wide transposon mutagenesis screens have identified numerous essential genes in the significant human pathogen Streptococcus pyogenes (group A Streptococcus or GAS), many of their functions remain elusive. This knowledge gap is attributed in part to the limited molecular toolbox for controlling GAS gene expression and the bacterium’s poor genetic transformability. CRISPR interference (CRISPRi), using catalytically inactive GAS Cas9 (dCas9), is a powerful approach to specifically repress gene expression in both bacteria and eukaryotes, but ironically, it has never been harnessed for controlled gene expression in GAS. In this study, we present a highly transformable and fully virulent serotype M1T1 GAS strain and introduce a doxycycline-inducible CRISPRi system for efficient repression of bacterial gene expression. We demonstrate highly efficient, oligo-based single guide RNA cloning directly to GAS, enabling the construction of a gene knockdown strain in just 2 days, in contrast to the several weeks typically required. The system is shown to be titratable and functional both in vitro and in vivo using a murine model of GAS infection. Furthermore, we provide direct in vivo evidence that the expression of the conserved cell division gene ftsZ is essential for GAS virulence, highlighting its promise as a target for emerging FtsZ inhibitors. Finally, we introduce SpyBrowse ( https://veeninglab.com/SpyBrowse ), a comprehensive and user-friendly online resource for visually inspecting and exploring GAS genetic features. The tools and methodologies described in this work are poised to facilitate fundamental research in GAS, contribute to vaccine development, and aid in the discovery of antibiotic targets. IMPORTANCE While group A Streptococcus (GAS) remains a predominant cause of bacterial infections worldwide, there are limited genetic tools available to study its basic cell biology. Here, we bridge this gap by creating a highly transformable, fully virulent M1T1 GAS strain. In addition, we established a tight and titratable doxycycline-inducible system and developed CRISPR interference (CRISPRi) for controlled gene expression in GAS. We show that CRISPRi is functional in vivo in a mouse infection model. Additionally, we present SpyBrowse, an intuitive and accessible genome browser ( https://veeninglab.com/SpyBrowse ). Overall, this work overcomes significant technical challenges of working with GAS and, together with SpyBrowse, represents a valuable resource for researchers in the GAS field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of California San Diego, La Jolla, California, USA.
- Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
- Department of Oral Rehabilitation and Biosciences, School of Dentistry, Oregon Health & Science University, Portland, Oregon, USA.
- Genomic Medicine Group, J. Craig Venter Institute, La Jolla, California, USA.
- School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, New York, USA.
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, USA.
ORCID-Profile: Elisabet Bjånes, Alexandra Stream, Axel B Janssen, Jonathon L Baker, Victor Nizet, Jan-Willem Veening
Förderung
- NIAID NIH HHS
- NIDCR NIH HHS
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF)
Zitieren
APA
Bjånes, E., Stream, A., Janssen, A. B., Gibson, P. S., Bravo, A. M., Dahesh, S., Baker, J. L., Varble, A., Nizet, V., & Veening, J. W. (2024). An efficient in vivo -inducible CRISPR interference system for group A Streptococcus genetic analysis and pathogenesis studies. mBio, 15(8). https://doi.org/10.1128/mbio.00840-24
Vancouver
Bjånes E, Stream A, Janssen AB, Gibson PS, Bravo AM, Dahesh S, et al. An efficient in vivo -inducible CRISPR interference system for group A Streptococcus genetic analysis and pathogenesis studies. mBio. 2024;15(8). doi:10.1128/mbio.00840-24
BibTeX
@article{Bjnes2024,
author = {Bjånes, Elisabet and Stream, Alexandra and Janssen, Axel B and Gibson, Paddy S and Bravo, Afonso M and Dahesh, Samira and Baker, Jonathon L and Varble, Andrew and Nizet, Victor and Veening, Jan-Willem},
title = {An efficient in vivo -inducible CRISPR interference system for group A Streptococcus genetic analysis and pathogenesis studies},
journal = {mBio},
year = {2024},
volume = {15},
number = {8},
doi = {10.1128/mbio.00840-24}
}
EUVIMED